Simvastatin 40mg (DrugBank: Simvastatin)
21 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
6 | Parkinson disease | 0 |
13 | Multiple sclerosis/Neuromyelitis optica | 0 |
15 | Inclusion body myositis | 0 |
34 | Neurofibromatosis | 0 |
46 | Malignant rheumatoid arthritis | 0 |
49 | Systemic lupus erythematosus | 0 |
51 | Scleroderma | 0 |
66 | IgA nephropathy | 0 |
79 | Homozygous familial hypercholesterolemia | 0 |
86 | Pulmonary arterial hypertension | 0 |
89 | Lymphangioleiomyomatosis | 0 |
94 | Primary sclerosing cholangitis | 1 |
158 | Tuberous sclerosis | 0 |
160 | Congenital ichthyosis | 0 |
162 | Pemphigoid | 0 |
195 | Noonan syndrome | 0 |
265 | Lipodystrophy | 0 |
288 | Autoimmune acquired coagulation factor deficiency [Autoimmune Hemorrhaphilia XIII (~Mar 2017)] | 0 |
298 | Hereditary pancreatitis | 0 |
299 | Cystic fibrosis | 0 |
310 | Congenital anomalies syndrome | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04133792 (ClinicalTrials.gov) | October 1, 2020 | 17/10/2019 | Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC) | Effect of Simvastatin on the Prognosis of Primary Sclerosing Cholangitis (PSC); A Randomized, Double-blind, Placebo Controlled Multicenter Study | Primary Sclerosing Cholangitis | Drug: Simvastatin 40mg;Drug: Placebo oral tablet | Annika Bergquist | NULL | Recruiting | 18 Years | 75 Years | All | 700 | Phase 3 | Sweden |